We are live on
!
Find out more
CWM
CIBC World Markets Portfolio holdings
AUM
$20.8B
This Fund
S&P 500
This Quarter
Est. Return
-3.31%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$12.7B
AUM Growth
-$4.36B
(-26%)
Cap. Flow
-$3.8B
Cap. Flow
% of AUM
-29.89%
Top 10 Holdings %
Top 10 Hldgs %
38.21%
Holding
1,893
New
568
Increased
757
Reduced
513
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$211M |
| 2 |
Crown Castle
CCI
|
+$52.2M |
| 3 |
Tesla
TSLA
|
+$46.6M |
| 4 |
XP
XP
|
+$25.2M |
| 5 |
EA
Electronic Arts
EA
|
+$22.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$587M |
| 2 |
Honeywell
HON
|
+$142M |
| 3 |
Mastercard
MA
|
+$126M |
| 4 |
Apple
AAPL
|
+$111M |
| 5 |
Meta Platforms (Facebook)
META
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.12% |
| 2 | Financials | 11.86% |
| 3 | Consumer Discretionary | 10.19% |
| 4 | Communication Services | 9.97% |
| 5 | Healthcare | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACCD
1576
DELISTED
Accolade Inc
ACCD
| $116K | ﹤0.01% |
+16,549
| New | +$111K |
|
|
BORR
1577
Borr Drilling
BORR
$1.19B
| $115K | ﹤0.01% |
52,603
+30,417
| +137% | +$91.6K |
|
1578
Rocket Pharmaceuticals
RCKT
$394M
| $114K | ﹤0.01% |
+17,102
| New | +$169K |
|
|
MTAL
1579
DELISTED
Metals Acquisition
MTAL
| $114K | ﹤0.01% |
+11,953
| New | +$126K |
|
1580
N-able
NABL
$940M
| $114K | ﹤0.01% |
+16,074
| New | +$143K |
|
1581
Arbutus Biopharma
ABUS
$915M
| $113K | ﹤0.01% |
32,417
+18,745
| +137% | +$62.5K |
|
1582
JELD-WEN Holding
JELD
$164M
| $112K | ﹤0.01% |
+18,744
| New | +$139K |
|
1583
Nordic American Tanker
NAT
$1.37B
| $111K | ﹤0.01% |
45,231
+26,154
| +137% | +$68.9K |
|
1584
Kura Oncology
KURA
$850M
| $108K | ﹤0.01% |
+16,424
| New | +$128K |
|
|
NPKI
1585
NPK International
NPKI
$1.14B
| $108K | ﹤0.01% |
+18,657
| New | +$124K |
|
|
TRTX
1586
TPG RE Finance Trust
TRTX
$618M
| $108K | ﹤0.01% |
+13,234
| New | +$112K |
|
1587
Ivanhoe Electric
IE
$1.74B
| $108K | ﹤0.01% |
+18,548
| New | +$118K |
|
1588
Repay Holdings
RPAY
$327M
| $107K | ﹤0.01% |
+19,244
| New | +$132K |
|
1589
Invesco Mortgage Capital
IVR
$805M
| $107K | ﹤0.01% |
+13,575
| New | +$114K |
|
1590
Cytek Biosciences
CTKB
$546M
| $106K | ﹤0.01% |
26,429
+15,071
| +133% | +$78.1K |
|
1591
Immunome
IMNM
$2.83B
| $106K | ﹤0.01% |
+15,733
| New | +$151K |
|
1592
Trevi Therapeutics
TRVI
$2.63B
| $104K | ﹤0.01% |
+16,534
| New | +$78.9K |
|
|
DCH
1593
Dauch Corp
DCH
$1.51B
| $104K | ﹤0.01% |
25,511
+14,752
| +137% | +$75.7K |
|
1594
RPC Inc
RES
$1.3B
| $104K | ﹤0.01% |
+18,858
| New | +$112K |
|
1595
Cipher Digital
CIFR
$7.13B
| $103K | ﹤0.01% |
44,940
+25,986
| +137% | +$118K |
|
1596
ImmunityBio
IBRX
$8.1B
| $102K | ﹤0.01% |
33,912
+20,366
| +150% | +$61.7K |
|
1597
Omeros
OMER
$959M
| $102K | ﹤0.01% |
+12,411
| New | +$110K |
|
|
CTLP
1598
DELISTED
Cantaloupe
CTLP
| $102K | ﹤0.01% |
+12,960
| New | +$115K |
|
1599
FTAI Infrastructure
FIP
$505M
| $101K | ﹤0.01% |
+22,348
| New | +$140K |
|
1600
SelectQuote
SLQT
$121M
| $101K | ﹤0.01% |
30,135
+17,426
| +137% | +$73.9K |
|
Similar funds
VRS
FAF
BGIM
CIM
PPFA
UOC
FNBT
CIBC World Markets's Q1 2025 Portfolio in Review
As of Q1 2025, CIBC World Markets held 1,893 positions worth $12.7B, down 26% from $17.1B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
CIBC World Markets withdrew a net $3.8B in Q1 2025, closing 51 positions and reducing 513 holdings. Its most notable exit was Apellis Pharmaceuticals, an estimated $41M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, CIBC World Markets opened a new position in XP worth $25.2M.
- CIBC World Markets's largest Q1 2025 buy was XP: 1,832,600 shares worth $25.2M.
- CIBC World Markets added most to Microsoft in Q1 2025, an estimated $211M increase.
- CIBC World Markets's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $587M.
- CIBC World Markets fully exited Apellis Pharmaceuticals in Q1 2025, selling an estimated $41M.
- CIBC World Markets's ten largest holdings make up 38% of its $12.7B portfolio in Q1 2025.
- CIBC World Markets opened 568 new positions and closed 51 in Q1 2025.
- CIBC World Markets's portfolio value fell 26% quarter-over-quarter to $12.7B.
Based on CIBC World Markets's 13F filing for Q1 2025, filed 13 May 2025.